Results 201 to 210 of about 48,358 (306)
Cutaneous lymphatics and skin diseases: mechanisms, imaging modalities, and future therapeutic strategies. [PDF]
Chen N +6 more
europepmc +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Skeletal manifestations in lymphatic diseases: nonenhanced magnetic resonance lymphography. [PDF]
Cholet C +5 more
europepmc +1 more source
ABSTRACT Background Postoperative radiotherapy is the standard treatment for locally advanced oral squamous cell carcinoma (OSCC); however, the indication for neck irradiation (NI) in pN0 patients remains debatable. We evaluated whether the omission of NI compromises outcomes in pT3–T4 pN0 patients treated with adequate neck dissection (ND).
Mathilde Mirallié +9 more
wiley +1 more source
Case Report of Cystic Mesenteric Lymphangioma as a Cause of Small Bowel Obstruction in an Adult with a Virgin Abdomen. [PDF]
Singh N, Petrancosta J, Ahmed S, Ahn N.
europepmc +1 more source
ABSTRACT Background Locoregional recurrence remains a clinically relevant problem in oral squamous cell carcinoma (OSCC). Whether local, ipsilateral nodal, and contralateral nodal failure represent distinct disease processes with different clinicopathological associations has not been systematically evaluated.
Jannik Ketschau +9 more
wiley +1 more source
Unexpected hepatic lymphangiography during transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma: a case report. [PDF]
Mori T +4 more
europepmc +1 more source
ABSTRACT Objective To provide a comprehensive review of the biological rationale, clinical evidence, and practical perioperative management of immunotherapy for the head and neck surgeon. Summary Background Data Standard treatment for resectable head and neck squamous cell carcinoma (HNSCC) has reached a survival plateau, with over 50% of patients ...
Nicholas Brian Shannon, Bruce Ashford
wiley +1 more source

